Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trialWinette T.A. van der Graaf, Peter Hohenberger, M. Ouali et al.|The Lancet|2012Cited by 2.1k
Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trialIan Judson, Winette T.A. van der Graaf, Jaap Verweij et al.|The Lancet Oncology|2014Cited by 1.2k
Diagnosis and management of tropomyosin receptor kinase (TRK) fusion sarcomas: expert recommendations from the World Sarcoma NetworkGeorge D. Demetri, Jean‐Yves Blay, Cristina R. Antonescu et al.|Annals of Oncology|2020Cited by 145
Predicting IGF-1R Therapy Response in Bone Sarcomas: Immuno-SPECT Imaging with Radiolabeled R1507Emmy D.G. Fleuren, Winette T.A. van der Graaf|Clinical Cancer Research|2011Cited by 42
Olaparib and temozolomide in desmoplastic small round cell tumors: a promising combination in vitro and in vivoAnke van Erp, Winette T.A. van der Graaf|Journal of Cancer Research and Clinical Oncology|2020Cited by 27